Literature DB >> 12624092

Structure of the GTPase-binding domain of Sec5 and elucidation of its Ral binding site.

Helen R Mott1, Daniel Nietlispach, Louise J Hopkins, Gladys Mirey, Jacques H Camonis, Darerca Owen.   

Abstract

The exocyst complex is involved in the final stages of exocytosis, when vesicles are targeted to the plasma membrane and dock. The regulation of exocytosis is vital for a number of processes, for example, cell polarity, embryogenesis, and neuronal growth formation. Regulation of the exocyst complex in mammals was recently shown to be dependent upon binding of the small G protein, Ral, to Sec5, a central component of the exocyst. This interaction is thought to be necessary for anchoring the exocyst to secretory vesicles. We have determined the structure of the Ral-binding domain of Sec5 and shown that it adopts a fold that has not been observed in a G protein effector before. This fold belongs to the immunoglobulin superfamily in a subclass known as IPT domains. We have mapped the Ral binding site on this domain and found that it overlaps with protein-protein interaction sites on other IPT domains but that it is completely different from the G protein-geranyl-geranyl interaction face of the Ig-like domain of the Rho guanine nucleotide dissociation inhibitor. This mapping, along with available site-directed mutagenesis data, allows us to predict how Ral and Sec5 may interact.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624092     DOI: 10.1074/jbc.M300155200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  The exocyst complex in exocytosis and cell migration.

Authors:  Jianglan Liu; Wei Guo
Journal:  Protoplasma       Date:  2011-10-14       Impact factor: 3.356

Review 2.  The Exocyst at a Glance.

Authors:  Bin Wu; Wei Guo
Journal:  J Cell Sci       Date:  2015-08-03       Impact factor: 5.285

Review 3.  Role of the epithelial cell-specific clathrin adaptor complex AP-1B in cell polarity.

Authors:  Heike Fölsch
Journal:  Cell Logist       Date:  2015-07-30

Review 4.  Exposing the Elusive Exocyst Structure.

Authors:  Dante M Lepore; Leonora Martínez-Núñez; Mary Munson
Journal:  Trends Biochem Sci       Date:  2018-07-25       Impact factor: 13.807

5.  Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex.

Authors:  Shuya Fukai; Hugo T Matern; Junutula R Jagath; Richard H Scheller; Axel T Brunger
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

6.  Ral mediates activity-dependent growth of postsynaptic membranes via recruitment of the exocyst.

Authors:  Rita O Teodoro; Gulçin Pekkurnaz; Abdullah Nasser; Misao E Higashi-Kovtun; Maria Balakireva; Ian G McLachlan; Jacques Camonis; Thomas L Schwarz
Journal:  EMBO J       Date:  2013-06-28       Impact factor: 11.598

7.  Structural determination of functional domains in early B-cell factor (EBF) family of transcription factors reveals similarities to Rel DNA-binding proteins and a novel dimerization motif.

Authors:  Marina I Siponen; Magdalena Wisniewska; Lari Lehtiö; Ida Johansson; Linda Svensson; Grzegorz Raszewski; Lennart Nilsson; Mikael Sigvardsson; Helena Berglund
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

8.  Exocyst function is regulated by effector phosphorylation.

Authors:  Xiao-Wei Chen; Dara Leto; Junyu Xiao; John Goss; Qian Wang; Jordan A Shavit; Tingting Xiong; Genggeng Yu; David Ginsburg; Derek Toomre; Zhaohui Xu; Alan R Saltiel
Journal:  Nat Cell Biol       Date:  2011-04-24       Impact factor: 28.824

9.  RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.

Authors:  Adriana O Santos; Maria Carla Parrini; Jacques Camonis
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

10.  Conservation of helical bundle structure between the exocyst subunits.

Authors:  Nicole J Croteau; Melonnie L M Furgason; Damien Devos; Mary Munson
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.